NFKB1 and lip and oral cavity carcinoma: Anti-proliferative, pro-apoptotic, cell-cycle regulatory and anti-angiogenic effects on oral cancer cells through inhibition of NF-κB and COX-2; chemopreventive or chemotherapeutic agent for the treatment of oral cancer [243].